Continuous Glucose Monitoring Market Will Grow at 14.8% CAGR Till 2020

April 24, 2014

PORTLAND, Oregon, April 24, 2014 /PRNewswire/ –

The database of Research Beam has a latest addition of report, titled “Continuous
Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age
Group) – Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth,
Opportunities and Global Forecasts, 2012 -2020.” This report prepared with insightful
analysis provides a microscopic view about continuous glucose monitoring market to
healthcare industry professionals. This extensively studied report is fully versed with
business insights and opportunistic ideas.

To browse the full report, visit us @


In 2012, the report observed the value of CGM to be $194.8 million. However, factors
such as rising awareness about CGM’s, earlier detection of hyperglycemic and hypo
condition, affectivity over conventional devices would take global CGM market to $568.5
million by 2020 with a CAGR of 14.8%.

“The market is overcoming several challenges towards the commercialization of closed
loop CGMs with significant focus on technological innovation. This is expected to take the
concept of CGM to a next level from research to mass adoption,” noted by analyst. Despite
such encouraging innovations, commercialization has not reached to desired levels. Major
factors responsible for this are issues related with accuracy as well as cost, less
attractive reimbursement coverage, and strict regulatory impositions. “However, the under
commercialization is presenting opportunities for the marketers as new and innovative
products will easily take the advantage of lower product presence,” Debbie explains. The
impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring
devices and rise in diabetes cases will have significant impact on the overall market

Similar market research reports at Research Beam:

Global Cardiovascular Surgical Devices and Technologies Market:

Cardiovascular surgery is the process performed to cure the heart tissue defects such
as replacing the diseased heart valves if it is blocked, grafting or replacement of heart
tissues in case of damage. There are two major types of heart surgeries performed, namely
closed and open types of surgeries. The global surgical device market is the parent market
for cardiovascular devices, which was valued at $240 billion in 2013. Increase in
incidence for heart related problems are mainly due to changes in life style. This life
style changes has increased the rate of heart surgeries. The U.S. is the leading market
for cardiovascular surgical devices due to increase in aging population that is suffering
from cardiovascular problems.

View the Global Cardiovascular Surgical Devices and Technologies Market report@


Plastic Processing Machinery Markets in China:

China’s demand for Plastic Processing Machinery has grown at a fast pace in the past
decade. In the next five years, both production and demand will continue to grow. This new
study examines China’s economic trends, investment environment, industry development,
supply and demand, industry capacity, industry structure, marketing channels and major
industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts
through 2018 and 2023 are presented. Major producers in China are profiled.

View the Plastic Processing Machinery Markets in China market research report @


Chinese guidebook for Medical Device Adverse Event Reporting and Monitoring
Regulations (2014 Edition):

China is one of the fastest growing global economies with a fifth population in the
world, and is one of the largest healthcare markets around the world. Along with sustained
economic and population growth, Chinese healthcare market has maintained annually average
growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare
market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made
by overseas and multinational pharmaceutical manufacturers account for about one fourth.
It is estimated that total value of drugs on Chinese healthcare market will be likely to
be more than 1450 billion RMB by 2015, and will surpass Japan to become the second largest
drug market following the United States. The Chinese healthcare market will attract more
and more overseas pharmaceutical manufacturers and producers to penetrate such market.

View the Chinese guidebook for Medical Device Adverse Event Reporting and Monitoring
Regulations report @


Global Wearable Medical Devices (Home Healthcare) Market:

Wearable medical devices are handheld monitoring tools used in identification and
monitoring of disease. Due to the Increase in chronic diseases, patients are opting home
healthcare as a cost effective and efficient way of treatment, rather than hospital
services. Medical device market accounted for $240 billion in 2013. However, increase in
incidence of chronic diseases restricts the growth of wearable medical device market.
Neurological diseases in people have increased to 7.2% in urban areas, causing hurdles for
monitoring through wearable medical devices.

View the Global Wearable Medical Devices (Home Healthcare) Market report @


Providing minutest details of every sector, this report divides Global CFM market on
the basis of age, devices, types of diabetes and application. A deep dive study by AMR
revealed the home settings market to lead the CGM application market in terms of revenue.
However, the application of GCM under application market would attract plethora of
investors between 2013 and 2020.

Study by AMR suggests that the receivers and transmitters attained highest revenue in
overall Global continuous glucose monitoring systems market with a value of $88.5 million
in 2012. However, during the analysis period, more improvements can be witnessed in
glucose sensors and hence, the report rightfully suggest that the glucose sensors would
generate the highest revenue during 2013 to 2020.

The report also provides a holistic views about geographies that play a vital role in
Global continuous glucose monitoring systems market. As per the latest findings by AMR,
North America has the highest growth in terms of revenue. Further, Asia Pacific is
expected to achieve highest growth rate during the forecast period.

To view all market research reports of this publisher, visit us @


This report gives you detailed insights about various companies involved in CGM
markets. The companies are listed below

        - Medtronic Inc.,
        - Dexcom Inc.,
        - Novo Nordisk,
        - Spring Health Solution Ltd,
        - Roche, Animas Corporation,
        - Ypsomed AG,
        - Insulet Corporation

About Us: We have a large database of quality and precise market research reports that
will be very beneficial for your organization. Reports that we sell our authentic in
nature and from reputed publishers, hence it can definitely help you with your growth

In order to survive the fierce competition and locate different avenues, one must be
privy to high end and quality market information. So, we try and provide you with latest
market information by getting high market research reports from our clients.

We have business relations with numerous clients of different verticals. Hence, we
bring to you market research reports of various fields and carter to number of
organizations. This is the spot on place for all your market research needs.

We are home to a very proactive and energetic team who strives to solve user queries
as soon as possible. They will also help you to know about latest market trends and

Research Beam will always make sure to bring most ethical and high quality reports. We
value your relationship with us and look forward for a long term relation.


        Sona Padman
        5320 SW Macadam Avenue,
        Suite 100, Portland, OR 97239
        United States
        Direct: +1(617)674-4143
        Toll Free: +1(855)711-1555 (U.S. & Canada)
        Fax: +1(855)550-5975
        Email: sales@researchbeam.com

SOURCE Research Beam

Source: PR Newswire

comments powered by Disqus